Acadia Pharma (ACAD) Misses Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $26.41 +0.08%
Revenue Growth %: +19.3%
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
NEOV, MANU, CTAS, More
Revenue Growth %: +19.3%
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.45), $0.03 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- JPMorgan Upgrades Graphic Packaging Holding Company (GPK) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
